In some cases, people will adjust to the side effects and when you skip the week, sometimes the side effects come back, Seltzer says
These data instill optimism about the impact that this drug might have in the treatment of T2DM and its complications in every day clinical practice
Our team will guide you on making diet adjustments to achieve the best outcomes from your medication
The LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) trial was a pivotal milestone as it showed the cardiovascular benefits of liraglutide in patients with T2D and high cardiovascular risk
The most frequently reported side effects include nausea, vomiting, diarrhea, constipation, stomach pain, and decreased appetite
District Judge Karen Marston